Brian G. Atwood - Mar 31, 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Director
Signature
/s/ Brian G. Atwood
Stock symbol
CERO
Transactions as of
Mar 31, 2025
Transactions value $
$59
Form type
4
Date filed
4/4/2025, 07:12 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERO Common Stock Options Exercise $29.40 +294K +150.18% $0.00 491K Mar 31, 2025 See Footnote F1
holding CERO Common Stock 1.25K Mar 31, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Pre-Funded Warrant Options Exercise $29.40 +294K $0.00 11.7K Mar 31, 2025 Common Stock 294K $0.00 Direct F2
holding CERO Pre-Funded Warrant 204K Mar 31, 2025 Common Stock 204K $0.00 By GVN, LLC F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 28, 2025, Mr. Atwood exercised Pre-Funded Warrants (the "Pre-Funded Warrants") and directed the issuance of the shares of common stock of CERo Therapeutics Holdings, Inc. (the "Issuer") to the Atwood-Edminster Trust dtd 4-2-2000 (the "Trust"). Mr. Atwood and his wife are the managers of the LLC and the trustees of the Trust. Accordingly, Mr. Atwood may be deemed to have beneficial ownership of the securities held directly by the LLC..
F2 The Pre-Funded Warrants are exercisable at any time on or after the date of issuance for an exercise price of $0.0001 per share, for shares of common stock of the Issuer.
F3 GVN, LLC (the "LLC") is a limited liability company of which the sole member is the Trust..